(Q44129463)

30 November 2017

title

Use of psychotropic medication in Alzheimer's disease is associated with more rapid cognitive and functional decline (English)

1 reference

30 November 2017

0 references

Edward C Lauterbach

1

1 reference

30 November 2017

publication date

7 March 2013

1 reference

30 November 2017

published in

Evidence-Based Medicine

1 reference

30 November 2017

volume

18

1 reference

30 November 2017

issue

5

1 reference

30 November 2017

page(s)

e50

1 reference

Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1136%2FEB-2013-101225

Benzodiazepine use and risk of dementia: prospective population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2013-101225

Psychotropic drug effects on gene transcriptomics relevant to Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2013-101225

Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2013-101225

Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FEB-2013-101225

21 January 2018

Identifiers

DOI

10.1136/EB-2013-101225

1 reference

30 November 2017

1 reference